Attributable mortality of ventilator-associated pneumonia: a reappraisal using causal analysis.

RATIONALE Measuring the attributable mortality of ventilator-associated pneumonia (VAP) is challenging and prone to different forms of bias. Studies addressing this issue have produced variable and controversial results. OBJECTIVES We estimate the attributable mortality of VAP in a large multicenter cohort using statistical methods from the field of causal inference. METHODS Patients (n = 4,479) from the longitudinal prospective (1997-2008) French multicenter Outcomerea database were included if they stayed in the intensive care unit (ICU) for at least 2 days and received mechanical ventilation (MV) within 48 hours after ICU admission. A competing risk survival analysis, treating ICU discharge as a competing risk for ICU mortality, was conducted using a marginal structural modeling approach to adjust for time-varying confounding by disease severity. MEASUREMENTS AND MAIN RESULTS Six hundred eighty-five (15.3%) patients acquired at least one episode of VAP. We estimated that 4.4% (95% confidence interval, 1.6-7.0%) of the deaths in the ICU on Day 30 and 5.9% (95% confidence interval, 2.5-9.1%) on Day 60 are attributable to VAP. With an observed ICU mortality of 23.3% on Day 30 and 25.6% on Day 60, this corresponds to an ICU mortality attributable to VAP of about 1% on Day 30 and 1.5% on Day 60. CONCLUSIONS Our study on the attributable mortality of VAP is the first that simultaneously accounts for the time of acquiring VAP, informative loss to follow-up after ICU discharge, and the existence of complex feedback relations between VAP and the evolution of disease severity. In contrast to the majority of previous reports, we detected a relatively limited attributable ICU mortality of VAP.

[1]  S. Vansteelandt,et al.  Reply to Wolkewitz et al. , 2010, Intensive Care Medicine.

[2]  J. Rello,et al.  Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units , 2009, Critical care medicine.

[3]  J. Robins,et al.  Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. , 2000, Epidemiology.

[4]  M Schumacher,et al.  Attributable Mortality due to Nosocomial Infections , 2007, Methods of Information in Medicine.

[5]  S. Chevret,et al.  Mortality of nosocomial pneumonia in ventilated patients: influence of diagnostic tools. , 1996, American journal of respiratory and critical care medicine.

[6]  R. Prentice Observational studies, clinical trials, and the women’s health initiative , 2007, Lifetime data analysis.

[7]  James M. Robins,et al.  Observational Studies Analyzed Like Randomized Experiments: An Application to Postmenopausal Hormone Therapy and Coronary Heart Disease , 2008, Epidemiology.

[8]  Jonathan AC Sterne,et al.  Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study , 2005, The Lancet.

[9]  K. Peter,et al.  Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical trial. , 2002, American journal of respiratory and critical care medicine.

[10]  A Bueno-Cavanillas,et al.  Influence of nosocomial infection on mortality rate in an intensive care unit , 1994, Critical care medicine.

[11]  A note on statistical association and causality derived from epidemiological ICU data , 2010, Intensive Care Medicine.

[12]  M. Rué,et al.  Survival in patients with nosocomial pneumonia: impact of the severity of illness and the etiologic agent. , 1997, Critical care medicine.

[13]  Jin Tian,et al.  Probabilities of causation: Bounds and identification , 2000, Annals of Mathematics and Artificial Intelligence.

[14]  S. Lemeshow,et al.  A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study , 1993 .

[15]  J. Carlet Dying from or with a nosocomial pneumonia in the intensive care unit? , 2001, Critical care medicine.

[16]  S. Walter The estimation and interpretation of attributable risk in health research. , 1976, Biometrics.

[17]  M. Rovers,et al.  Ventilator‐associated pneumonia and mortality: A systematic review of observational studies * , 2009, Critical care medicine.

[18]  R. Hotchkiss,et al.  Immunotherapy for sepsis--a new approach against an ancient foe. , 2010, The New England journal of medicine.

[19]  Elie Azoulay,et al.  Attributable mortality of ventilator-associated pneumonia: respective impact of main characteristics at ICU admission and VAP onset using conditional logistic regression and multi-state models , 2010, Intensive Care Medicine.

[20]  Martin Schumacher,et al.  Risk factors for the development of nosocomial pneumonia and mortality on intensive care units: application of competing risks models , 2008, Critical care.

[21]  S. Chevret,et al.  Evaluating mortality in intensive care units: contribution of competing risks analyses , 2005, Critical care.

[22]  J. Muscedere Ventilator-associated pneumonia and mortality: the controversy continues. , 2009, Critical care medicine.

[23]  J. Satagopan,et al.  A note on competing risks in survival data analysis , 2004, British Journal of Cancer.

[24]  J. Vincent,et al.  The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure , 1996, Intensive Care Medicine.

[25]  S. Lemeshow,et al.  A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. , 1993, JAMA.

[26]  Sanjay Saint,et al.  Clinical and economic consequences of ventilator-associated pneumonia: A systematic review , 2005, Critical care medicine.

[27]  J. Robins,et al.  Marginal Structural Models and Causal Inference in Epidemiology , 2000, Epidemiology.

[28]  A. Harris,et al.  Risk of mortality with a bloodstream infection is higher in the less severely ill at admission. , 2005, American journal of respiratory and critical care medicine.

[29]  S. Greenland Quantifying Biases in Causal Models: Classical Confounding vs Collider-Stratification Bias , 2003, Epidemiology.

[30]  M. Schumacher,et al.  Modeling the effect of time-dependent exposure on intensive care unit mortality , 2009, Intensive Care Medicine.

[31]  S. Vansteelandt,et al.  Adjusting for time-varying confounding in the subdistribution analysis of a competing risk , 2010, Lifetime data analysis.

[32]  V T Farewell,et al.  The analysis of failure times in the presence of competing risks. , 1978, Biometrics.

[33]  Marin H Kollef,et al.  Risk factors for ventilator-associated pneumonia: from epidemiology to patient management. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  M. Herridge Building consensus on ICU-acquired weakness , 2008, Intensive Care Medicine.